cytogenesis


Also found in: Dictionary, Thesaurus, Wikipedia.

cytogenesis

 [si″to-jen´ĕ-sis]
the origin and development of the cell.

cy·to·gen·e·sis

(sī'tō-jen'ĕ-sis),
The origin and development of cells.
[cyto- + G. genesis, origin]

cytogenesis

/cy·to·gen·e·sis/ (-jen´ĕ-sis) the origin and development of cells.

cytogenesis

(sī′tō-jĕn′ĭ-sĭs)
n.
The formation, development, and variation of cells. Also called cytogeny.

cytogenesis

[sī′tōjen′əsis]
Etymology: Gk, kytos + genein, to produce
the origin, development, and differentiation of cells. cytogenetics, n. cytogenic, adj.

cy·to·gen·e·sis

(sī'tō-jen'ĕ-sis)
The origin and development of cells.
[cyto- + G. genesis, origin]

cytogenesis

the origin and development of the cell.
Mentioned in ?
References in periodicals archive ?
CytoGenesis is a biotechnology company focussed on improving the treatment of Parkinson's disease utilizing cell therapy in combination with proprietary cell delivery and imaging systems.
The other technology Cytogenesis brings is a proprietary imaging and cell delivery system that encompasses specially designed probes.
BresaGen and CytoGenesis have 18 patent filings with the initial focus on treatment of severe, currently incurable, neurological diseases and disorders.
BresaGen recently announced the signing of a letter of intent to acquire CytoGenesis, Incorporated, a US based company with expertise in the area of cell delivery and imaging technology.
Listed Australian biotechnology company BresaGen Limited (ASX: BGN) today announced the signing of a letter of intent to acquire CytoGenesis, Incorporated, a US-based biotechnology company, through the issue of seven million new BresaGen shares and two million options.
CytoGenesis is a biotechnology company whose mission is to improve the treatment of Parkinson's disease utilizing cell therapy in combination with proprietary cell delivery and imaging systems.